Definitive Contract 140D0426C0006
- Not listed
- This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Insilicom LLC, a woman-owned, minority-owned small business. The contract is for SBIR (Small Business Innovation Research) Topic 136 - INSILICOM, which involves developing advanced artificial intelligence and knowledge graph technologies for biomedical research and applications. The contract has no set-aside designation and is focused on creating...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. The $355,000 Firm Fixed Price contract was awarded to Insilicom LLC, a minority-owned and woman-owned small business, to develop a proof-of-concept technology for drug repurposing targeting rare cancers using a large-scale, high-quality biomedical knowledge graph. The original contract opportunity was a...
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Biosensics LLC, a small business located in Newtonville, Massachusetts. The contract is for the development of an automated screening platform to enable early identification of malnutrition in cancer patients. This contract award is part of the FY24 SBIR solicitation, which covers a variety of research topics...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...
- This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Infotech Soft Inc., a woman-owned small business. The $224,683 firm fixed-price contract is for the "SBIR TOPIC 341 PH I METABOLOMICS DATA INTEGRATION AND QUALITY ASSESSMENT" project, which aims to develop advanced technological solutions for medical research and diagnostic capabilities. The contract has a total small business set-aside designation and was awarded on...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Babel Analytics LLC, a self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company. The contract, valued at $447,633.00, is for the development of Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. This SBIR Phase I...
- This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...
The National Institutes of Health (NIH) awarded a $600,000 definitive contract on February 23, 2026, to Insilicom LLC, a woman-owned and minority-owned small business, to develop personalized nutrition planning solutions leveraging iKraph technology for cancer prevention and management. The contract carries a total small business set-aside designation and is scheduled for completion by March 1, 2028, with performance to be conducted in Tallahassee, Florida. Insilicom specializes in artificial intelligence and knowledge graph technologies for biomedical research, utilizing natural language processing and machine learning to transform unstructured scientific literature into structured, actionable knowledge resources. This award aligns with Insilicom's core competencies in developing AI-powered solutions for healthcare applications and builds on the company's previous experience with NIH institutes, including the National Cancer Institute and the National Institute of Allergy and Infectious Diseases. The firm has a demonstrated track record of delivering Small Business Innovation Research (SBIR) projects focused on innovative approaches to complex biomedical challenges, with prior contract values ranging from $300,000 to $355,000. The personalized nutrition planning initiative represents an extension of Insilicom's expertise in applying knowledge graph methodologies to advance cancer research and patient care outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $600.0k | 2/22/26 |